New Post-Hoc Analysis Explores Daily Oral Orforglipron Use in Adults Over 65 with Obesity, Regardless of Diabetes Status
A groundbreaking new analysis set to be unveiled at the European Congress on Obesity (ECO 2026) in Istanbul delves into the efficacy and safety of...
















